Canada markets closed

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.8054+0.0054 (+0.30%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 14.37M
Enterprise Value 75.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.20
Price/Book (mrq)5.11
Enterprise Value/Revenue 1.05
Enterprise Value/EBITDA -2.85

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 3-66.43%
S&P500 52-Week Change 321.23%
52 Week High 35.6000
52 Week Low 31.7900
50-Day Moving Average 32.1954
200-Day Moving Average 32.8684

Share Statistics

Avg Vol (3 month) 398.56k
Avg Vol (10 day) 324.5k
Shares Outstanding 57.64M
Implied Shares Outstanding 67.64M
Float 869.35M
% Held by Insiders 129.31%
% Held by Institutions 139.27%
Shares Short (Mar 28, 2024) 41.16k
Short Ratio (Mar 28, 2024) 40.07
Short % of Float (Mar 28, 2024) 40.02%
Short % of Shares Outstanding (Mar 28, 2024) 40.02%
Shares Short (prior month Feb 29, 2024) 415.3k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 41.19
Payout Ratio 40.00%
Dividend Date 3Jul 01, 2015
Ex-Dividend Date 4Jun 05, 2015
Last Split Factor 21:5
Last Split Date 3Feb 23, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -42.26%
Operating Margin (ttm)-25.98%

Management Effectiveness

Return on Assets (ttm)-13.15%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)56.83M
Revenue Per Share (ttm)7.42
Quarterly Revenue Growth (yoy)-25.60%
Gross Profit (ttm)N/A
EBITDA -14.16M
Net Income Avi to Common (ttm)-36.87M
Diluted EPS (ttm)-4.9600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.69M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)54.86M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.60
Book Value Per Share (mrq)-3.12

Cash Flow Statement

Operating Cash Flow (ttm)-11.56M
Levered Free Cash Flow (ttm)-11.02M